德维喜DOVC品牌怎么样 申请店铺

我要投票 德维喜DOVC在其他行业中的票数:117 更新时间:2025-01-15
德维喜DOVC是哪个国家的品牌?「德维喜DOVC」是 东北制药集团股份有限公司 旗下著名品牌。该品牌发源于辽宁省沈阳市,由创始人魏海军在1993-06-10期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
德维喜DOVC怎么样

创始于1993年,知名维生素品牌,覆盖医药研发、制造、分销全产业链条,以化学原料药为主的大型综合性制药企业


东北制药集团股份有限公司(简称“东北制药”,股票代码:000597),是辽宁方大集团实业有限公司(简称“方大集团”)旗下上市公司。公司前身为东北制药总厂,始建于1946年,曾援建全国19省市52家医药企业,向外输送干部1300多人。

目前,东北制药拥有化学原料药、化学制剂、医药商业、医药工程、生物医药等主要业务板块,覆盖医药研发、制造、分销全产业链条,员工队伍9300余人,总资产120亿元。公司主要生产维生素系列药品、抗感染系统用药、妇产科系统用药、消化系统用药、泌尿系统用药、抗病毒系列用药、心脑血管系列用药、镇痛镇咳系列用药、生物诊断系列、大健康领域系列等十大系列精品,400多种化学原料药、医药中间体和制剂产品,主导产品远销100多个国家和地区。

公司拥有强大的产品制造体系。制剂生产基地占地18万平方米,拥有生产线30余条,年产能100亿片(支、丸、粒、枚、瓶)。原料药生产基地占地91万平方米,是国家大宗原料药和医药中间体智能制造示范工厂,主要产品包括维生素C及系列、左旋肉碱系列、磷霉素系列、吡拉西坦、卡前列甲酯、金刚烷胺、硫糖铝、黄连素、氯霉素等,并向下游东北制药制剂产业链延伸,形成难以复制的综合竞争优势。

东北制药不仅是中国重要的药品生产与出口基地,还设有药物研究院、工程设计公司、装备制造安装公司、国际贸易公司、计量检测公司、危化品运输公司等各独立业务公司。

东北制药医药商业业务网络覆盖辽宁全部地级市县,并向东北三省延伸,东北大药房拥有百余家连锁店,医药电商业务实现线上线下一体化,商业模式创新持续推进。


Founded in 1993, it is a well-known vitamin brand, covering the whole industrial chain of pharmaceutical research and development, manufacturing and distribution. Northeast Pharmaceutical Group Co., Ltd., a large comprehensive pharmaceutical enterprise mainly engaged in chemical APIs (hereinafter referred to as "Northeast Pharmaceutical", stock code: 000597), is a listed company under Liaoning Fangda Group Industry Co., Ltd. (hereinafter referred to as "Fangda group"). The company, formerly known as the Northeast Pharmaceutical General Factory, was founded in 1946. It has assisted in the construction of 52 pharmaceutical enterprises in 19 provinces and cities across the country, and has sent more than 1300 cadres. At present, Northeast Pharmaceutical has major business sectors such as chemical APIs, chemicals, pharmaceutical commerce, pharmaceutical engineering, biomedicine, covering the whole industrial chain of pharmaceutical research and development, manufacturing, distribution, with more than 9300 employees and a total asset of 12 billion yuan. The company mainly produces ten series of high-quality products, including vitamin series, anti infection system medicine, gynecology and obstetrics system medicine, digestive system medicine, urinary system medicine, anti-virus series medicine, cardiovascular and cerebrovascular series medicine, analgesia and antitussive series medicine, biological diagnosis series, large health field series, more than 400 kinds of chemical APIs, pharmaceutical intermediates and preparation products, leading products It is exported to more than 100 countries and regions. The company has a strong product manufacturing system. The preparation production base covers an area of 180000 square meters, with more than 30 production lines and an annual production capacity of 10 billion tablets (pills, granules, tablets, bottles). The API production base covers an area of 910000 square meters. It is a national bulk API and pharmaceutical intermediate intelligent manufacturing demonstration factory. Its main products include vitamin C and series, L-carnitine series, fosfomycin series, piracetam, carboprost methyl ester, amantadine, sucralfate, berberine, chloramphenicol, etc. and it extends to the downstream Northeast Pharmaceutical industry chain, forming a hard to replicate Comprehensive competitive advantage. Northeast Pharmaceutical is not only an important pharmaceutical production and export base in China, but also has independent business companies such as pharmaceutical research institute, engineering design company, equipment manufacturing and installation company, international trade company, measurement and testing company, dangerous chemicals transportation company, etc. The Northeast Pharmaceutical business network covers all prefecture level cities and counties in Liaoning, and extends to three provinces in Northeast China. The Northeast pharmacy has more than 100 chain stores. The online and offline integration of pharmaceutical e-commerce business is realized, and the innovation of business model is continuously promoted.

本文链接: https://brand.waitui.com/aa403ad85.html 联系电话:02425806688

千城特选小程序码

7×24h 快讯

上海:今年出台自贸区制度型开放2.0版方案

上海市第十六届人大三次会议1月15日上午在世博中心开幕。上海市市长龚正作《政府工作报告》。报告指出,要加快推进自贸试验区及临港新片区建设。深入落实自贸试验区提升战略,推动出台自贸试验区制度型开放2.0版方案,建设第二批自贸试验区联动创新区。深化增值电信业务扩大开放试点,推动洋山特殊综合保税区拓展保税研发、保税维修等新业态,扩大外资班轮沿海捎带、国际中转集拼、汽车国际分拨等业务规模。加快建设国际数据港先导区、国际数据经济产业园,完善数据跨境流动“负面清单+操作指引”统一管理机制。推进中意临港创新合作产业园、日企(上海)中小企业国际产业园建设。(上观)

38分钟前

旅游板块盘初走强,张家界直线涨停

36氪获悉,截至发稿,旅游板块盘初走强,张家界直线涨停,九华旅游、西安旅游、全聚德、西安饮食、君亭酒店等跟涨。

38分钟前

上海:培育壮大低空经济、大飞机等战略性新兴产业和未来产业

上海市第十六届人大三次会议1月15日上午在世博中心开幕。上海市市长龚正作《政府工作报告》。龚正说,要推动产业转型升级。着眼产业高端化,深入实施三大先导产业新一轮“上海方案”,优化集成电路产业空间布局,全链条加速生物医药产业创新发展,加快推进人工智能产业创新高地建设,培育壮大低空经济、大飞机、新能源汽车、智能终端、海洋装备、空间信息、机器人等战略性新兴产业和未来产业,健全保持制造业合理比重投入机制。着眼产业智能化,加快工业互联网规模化应用,持续推进智能工厂建设和智能机器人研发应用,大力培育发展智能经济形态。(上观)

38分钟前

银行股震荡拉升,招商银行涨近3%

36氪获悉,截至发稿,银行股震荡拉升,招商银行涨近3%,渝农商行、交通银行、兴业银行、浦发银行涨超2%。

38分钟前

为旌科技已完成新一轮近亿元融资,加速端侧AI芯片布局

高端智能SOC芯片设计公司为旌科技近日已完成新一轮近亿元融资,本轮融资由深创投、临芯投资和明势创投等投资机构持续投资。本轮融资将主要用于核心产品的研发,并支撑下一步的市场拓展。除本轮股东外,为旌科技的投资人还包括华业天成、元璟资本、金浦投资、上海AI产业基金、大横琴等。为旌科技的团队则主要来自海思、中兴微和高通等公司。(新浪科技)

38分钟前

本页详细列出关于Sanpowa的品牌信息,含品牌所属公司介绍,Sanpowa所处行业的品牌地位及优势。
咨询